10 0 2 0 2 B-lower_bound
% 2 3 2 3 I-lower_bound
or 4 6 4 6 O
more 7 11 7 11 O
probability 12 23 12 23 B-clinical_variable
of 24 26 24 26 I-clinical_variable
BRCA 27 31 27 31 I-clinical_variable
mutation 32 40 32 40 I-clinical_variable
by 41 43 41 43 I-clinical_variable
BRCAPRO 44 51 44 51 I-clinical_variable
or 52 54 52 54 I-clinical_variable
similar 55 62 55 62 I-clinical_variable
model 63 68 63 68 I-clinical_variable

A 0 1 69 70 O
known 2 7 71 76 O
deleterious 8 19 77 88 O
mutation 20 28 89 97 O
in 29 31 98 100 O
BRCA1 32 37 101 106 O
, 37 38 106 107 O
BRCA2 39 44 108 113 O
, 44 45 113 114 O
PTEN 46 50 115 119 O
, 50 51 119 120 O
or 52 54 121 123 O
TP53 55 59 124 128 O
. 59 60 128 129 O
( 61 62 130 131 O
Note 62 66 131 135 O
: 66 67 135 136 O
The 68 71 137 140 O
participant 72 83 141 152 O
must 84 88 153 157 O
be 89 91 158 160 O
a 92 93 161 162 O
documented 94 104 163 173 O
carrier 105 112 174 181 O
to 113 115 182 184 O
meet 116 120 185 189 O
this 121 125 190 194 O
criterion 126 135 195 204 O
. 135 136 204 205 O
If 137 139 206 208 O
there 140 145 209 214 O
is 146 148 215 217 O
a 149 150 218 219 O
known 151 156 220 225 O
mutation 157 165 226 234 O
in 166 168 235 237 O
a 169 170 238 239 O
hereditary 171 181 240 250 O
breast 182 188 251 257 B-cancer
cancer 189 195 258 264 I-cancer
susceptibility 196 210 265 279 O
gene 211 215 280 284 O
in 216 218 285 287 O
a 219 220 288 289 O
participant 221 232 290 301 O
's 232 234 301 303 O
family 235 241 304 310 O
member 242 248 311 317 O
, 248 249 317 318 O
the 250 253 319 322 O
participant 254 265 323 334 O
herself 266 273 335 342 O
must 274 278 343 347 O
have 279 283 348 352 O
undergone 284 293 353 362 O
genetic 294 301 363 370 O
testing 302 309 371 378 O
as 310 312 379 381 O
per 313 316 382 385 O
National 317 325 386 394 O
Comprehensive 326 339 395 408 O
Cancer 340 346 409 415 O
Network 347 354 416 423 O
guidelines 355 365 424 434 O
to 366 368 435 437 O
be 369 371 438 440 O
eligible 372 380 441 449 O
per 381 384 450 453 O
this 385 389 454 458 O
criterion 390 399 459 468 O
. 399 400 468 469 O
) 400 401 469 470 O

Any 0 3 471 474 O
prior 4 9 475 480 O
malignancy 10 20 481 491 B-cancer

Baseline 0 8 492 500 O
mammogram 9 18 501 510 B-treatment
performed 19 28 511 520 O
within 29 35 521 527 O
90 36 38 528 530 B-upper_bound
days 39 43 531 535 I-upper_bound
prior 44 49 536 541 I-upper_bound
to 50 52 542 544 O
study 53 58 545 550 O
entry 59 64 551 556 O
, 64 65 556 557 O
done 66 70 558 562 O
on 71 73 563 565 O
a 74 75 566 567 O
digital 76 83 568 575 B-treatment
mammography 84 95 576 587 I-treatment
machine 96 103 588 595 I-treatment
, 103 104 595 596 O
that 105 109 597 601 O
are 110 113 602 605 O
reported 114 122 606 614 O
as 123 125 615 617 O
normal 126 132 618 624 O
or 133 135 625 627 O
benign 136 142 628 634 O

Baseline 0 8 635 643 O
mammographic 9 21 644 656 B-clinical_variable
density 22 29 657 664 I-clinical_variable
> 30 31 665 666 O
10 32 34 667 669 B-lower_bound
% 34 35 669 670 I-lower_bound
based 36 41 671 676 O
upon 42 46 677 681 O
the 47 50 682 685 O
classification 51 65 686 700 O
system 66 72 701 707 O
( 73 74 708 709 O
2 74 75 709 710 O
= 76 77 711 712 O
11 78 80 713 715 B-lower_bound
- 80 81 715 716 O
50 81 83 716 718 B-upper_bound
% 83 84 718 719 I-upper_bound
, 84 85 719 720 O
scattered 86 95 721 730 B-clinical_variable
fibroglandular 96 110 731 745 I-clinical_variable
densities 111 120 746 755 I-clinical_variable
; 120 121 755 756 O
3 122 123 757 758 O
= 124 125 759 760 O
51 126 128 761 763 B-lower_bound
- 128 129 763 764 O
75 129 131 764 766 O
% 131 132 766 767 O
, 132 133 767 768 O
heterogeneously 134 149 769 784 B-clinical_variable
dense 150 155 785 790 I-clinical_variable
; 155 156 790 791 O
4 157 158 792 793 O
= 159 160 794 795 O
> 161 162 796 797 O
75 162 164 797 799 O
% 164 165 799 800 O
, 165 166 800 801 O
extremely 167 176 802 811 B-clinical_variable
dense 177 182 812 817 I-clinical_variable
) 182 183 817 818 O

Bilateral 0 9 819 828 B-cancer
breast 10 16 829 835 I-cancer
implants 17 25 836 844 B-treatment

DCIS 0 4 845 849 B-cancer
or 5 7 850 852 O
previous 8 16 853 861 O
invasive 17 25 862 870 B-cancer
ductal 26 32 871 877 I-cancer
carcinoma 33 42 878 887 I-cancer

Diagnosis 0 9 888 897 O
of 10 12 898 900 O
lobular 13 20 901 908 B-cancer
carcinoma 21 30 909 918 I-cancer
in 31 33 919 921 I-cancer
situ 34 38 922 926 I-cancer
( 39 40 927 928 I-cancer
LCIS 40 44 928 932 I-cancer
) 44 45 932 933 I-cancer
, 45 46 933 934 O
atypical 47 55 935 943 B-treatment
ductal 56 62 944 950 I-treatment
, 62 63 950 951 O
or 64 66 952 954 O
lobular 67 74 955 962 B-cancer
hyperplasia 75 86 963 974 I-cancer

Eastern 0 7 975 982 B-clinical_variable
Cooperative 8 19 983 994 I-clinical_variable
Oncology 20 28 995 1003 I-clinical_variable
Group 29 34 1004 1009 I-clinical_variable
performance 35 46 1010 1021 I-clinical_variable
status 47 53 1022 1028 I-clinical_variable
of 54 56 1029 1031 O
0 57 58 1032 1033 B-lower_bound
- 58 59 1033 1034 O
1 59 60 1034 1035 B-upper_bound

Elevated 0 8 1036 1044 O
risk 9 13 1045 1049 O
of 14 16 1050 1052 O
breast 17 23 1053 1059 B-cancer
cancer 24 30 1060 1066 I-cancer
as 31 33 1067 1069 O
defined 34 41 1070 1077 O
by 42 44 1078 1080 O
at 45 47 1081 1083 O
least 48 53 1084 1089 O
one 54 57 1090 1093 B-lower_bound
of 58 60 1094 1096 O
the 61 64 1097 1100 O
following 65 74 1101 1110 O
categories 75 85 1111 1121 O
and 86 89 1122 1125 O
have 90 94 1126 1130 O
declined 95 103 1131 1139 O
tamoxifen 104 113 1140 1149 B-chronic_disease
and/or 114 120 1150 1156 O
raloxifene 121 131 1157 1167 B-treatment
therapy 132 139 1168 1175 I-treatment

Female 0 6 1176 1182 B-gender

Hormone 0 7 1183 1190 B-treatment
replacement 8 19 1191 1202 I-treatment
therapy 20 27 1203 1210 I-treatment
is 28 30 1211 1213 O
not 31 34 1214 1217 O
allowed 35 42 1218 1225 O
for 43 46 1226 1229 O
postmenopausal 47 61 1230 1244 O
participants 62 74 1245 1257 O

Modified 0 8 1258 1266 O
Gail 9 13 1267 1271 B-clinical_variable
/ 13 14 1271 1272 I-clinical_variable
CARE 14 18 1272 1276 I-clinical_variable
model 19 24 1277 1282 I-clinical_variable
risk 25 29 1283 1287 I-clinical_variable
at 30 32 1288 1290 O
5 33 34 1291 1292 B-upper_bound
years 35 40 1293 1298 I-upper_bound
â‰¥ 41 42 1299 1300 O
1.67 43 47 1301 1305 B-lower_bound
% 47 48 1305 1306 I-lower_bound

Must 0 4 1307 1311 O
agree 5 10 1312 1317 B-contraception_consent
to 11 13 1318 1320 I-contraception_consent
use 14 17 1321 1324 I-contraception_consent
effective 18 27 1325 1334 I-contraception_consent
consistent 28 38 1335 1345 I-contraception_consent
contraception 39 52 1346 1359 I-contraception_consent

Must 0 4 1360 1364 O
have 5 9 1365 1369 O
at 10 12 1370 1372 O
least 13 18 1373 1378 O
one 19 22 1379 1382 B-lower_bound
breast 23 29 1383 1389 O
available 30 39 1390 1399 O
for 40 43 1400 1403 O
imaging 44 51 1404 1411 B-treatment
and 52 55 1412 1415 O
biopsy 56 62 1416 1422 B-treatment
. 62 63 1422 1423 O
A 64 65 1424 1425 O
previously 66 76 1426 1436 O
irradiated 77 87 1437 1447 O
breast 88 94 1448 1454 O
( 95 96 1455 1456 O
i.e. 96 100 1456 1460 O
, 100 101 1460 1461 O
for 102 105 1462 1465 O
resected 106 114 1466 1474 O
DCIS 115 119 1475 1479 B-cancer
) 119 120 1479 1480 O
is 121 123 1481 1483 O
not 124 127 1484 1487 O
evaluable 128 137 1488 1497 O
for 138 141 1498 1501 O
breast 142 148 1502 1508 B-treatment
imaging 149 156 1509 1516 I-treatment
or 157 159 1517 1519 O
biopsy 160 166 1520 1526 O

Must 0 4 1527 1531 O
not 5 8 1532 1535 O
participate 9 20 1536 1547 O
in 21 23 1548 1550 O
any 24 27 1551 1554 O
other 28 33 1555 1560 B-treatment
clinical 34 42 1561 1569 I-treatment
trial 43 48 1570 1575 I-treatment
for 49 52 1576 1579 O
the 53 56 1580 1583 O
treatment 57 66 1584 1593 B-treatment
or 67 69 1594 1596 O
prevention 70 80 1597 1607 O
of 81 83 1608 1610 O
cancer 84 90 1611 1617 B-cancer
unless 91 97 1618 1624 O
they 98 102 1625 1629 O
are 103 106 1630 1633 O
no 107 109 1634 1636 O
longer 110 116 1637 1643 O
receiving 117 126 1644 1653 O
the 127 130 1654 1657 O
intervention 131 143 1658 1670 O
and 144 147 1671 1674 O
are 148 151 1675 1678 O
in 152 154 1679 1681 O
the 155 158 1682 1685 O
follow 159 165 1686 1692 O
- 165 166 1692 1693 O
up 166 168 1693 1695 O
phase 169 174 1696 1701 O
only 175 179 1702 1706 O
. 179 180 1706 1707 O
Participants 181 193 1708 1720 O
must 194 198 1721 1725 O
also 199 203 1726 1730 O
agree 204 209 1731 1736 O
not 210 213 1737 1740 O
to 214 216 1741 1743 O
join 217 221 1744 1748 O
such 222 226 1749 1753 O
a 227 228 1754 1755 O
trial 229 234 1756 1761 O
while 235 240 1762 1767 O
participating 241 254 1768 1781 O
in 255 257 1782 1784 O
this 258 262 1785 1789 O
study 263 268 1790 1795 O

Pregnant 0 8 1796 1804 B-pregnancy

Prior 0 5 1805 1810 B-treatment
anticoagulant 6 19 1811 1824 I-treatment
therapy 20 27 1825 1832 I-treatment
use 28 31 1833 1836 O
is 32 34 1837 1839 O
allowed 35 42 1840 1847 O
provided 43 51 1848 1856 O
therapy 52 59 1857 1864 O
is 60 62 1865 1867 O
discontinued 63 75 1868 1880 O
at 76 78 1881 1883 O
least 79 84 1884 1889 O
7 85 86 1890 1891 B-lower_bound
days 87 91 1892 1896 I-lower_bound
prior 92 97 1897 1902 I-lower_bound
to 98 100 1903 1905 I-treatment
the 101 104 1906 1909 I-treatment
breast 105 111 1910 1916 I-treatment
biopsy 112 118 1917 1923 I-treatment
in 119 121 1924 1926 O
order 122 127 1927 1932 O
to 128 130 1933 1935 O
reduce 131 137 1936 1942 O
the 138 141 1943 1946 O
risk 142 146 1947 1951 O
of 147 149 1952 1954 O
bleeding 150 158 1955 1963 O

Prior 0 5 1964 1969 B-treatment
breast 6 12 1970 1976 I-treatment
reduction 13 22 1977 1986 I-treatment
surgery 23 30 1987 1994 I-treatment

Prior 0 5 1995 2000 B-treatment
tamoxifen 6 15 2001 2010 I-treatment
or 16 18 2011 2013 O
raloxifene 19 29 2014 2024 B-treatment
use 30 33 2025 2028 O
in 34 36 2029 2031 O
the 37 40 2032 2035 O
past 41 45 2036 2040 B-upper_bound
1 46 47 2041 2042 I-upper_bound
year 48 52 2043 2047 I-upper_bound

Women 0 5 2048 2053 B-gender
with 6 10 2054 2058 O
a 11 12 2059 2060 O
baseline 13 21 2061 2069 O
mammographic 22 34 2070 2082 B-clinical_variable
density 35 42 2083 2090 I-clinical_variable
of 43 45 2091 2093 O
â‰¤ 46 47 2094 2095 O
10 48 50 2096 2098 B-upper_bound
% 50 51 2098 2099 I-upper_bound
( 52 53 2100 2101 O
1 53 54 2101 2102 O
= 55 56 2103 2104 O
â‰¤10 57 60 2105 2108 O
% 60 61 2108 2109 O
, 61 62 2109 2110 O
breasts 63 70 2111 2118 O
are 71 74 2119 2122 O
almost 75 81 2123 2129 O
entirely 82 90 2130 2138 O
fat 91 94 2139 2142 O
) 94 95 2142 2143 O

adequately 0 10 2144 2154 O
treated 11 18 2155 2162 O
basal 19 24 2163 2168 B-cancer
cell 25 29 2169 2173 I-cancer
or 30 32 2174 2176 O
squamous 33 41 2177 2185 B-cancer
cell 42 46 2186 2190 I-cancer
skin 47 51 2191 2195 I-cancer
cancer 52 58 2196 2202 I-cancer
and 59 62 2203 2206 O
in 63 65 2207 2209 B-cancer
situ 66 70 2210 2214 I-cancer
cervical 71 79 2215 2223 I-cancer
cancer 80 86 2224 2230 I-cancer

aged 0 4 2231 2235 B-age
â‰¥18 5 8 2236 2239 O
years 9 14 2240 2245 I-lower_bound
of 15 17 2246 2248 O
age 18 21 2249 2252 O

